Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
25%
Ph phase_2
2
25%
Ph not_applicable
4
50%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
4(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(5)

Detailed Status

Completed5
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (25.0%)
Phase 42 (25.0%)
N/A4 (50.0%)

Trials by Status

completed563%
recruiting225%
not_yet_recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8